Clinical Trial Detail

NCT ID NCT03186118
Title Pilot Study of T-APCs Following CAR T Cell Immunotherapy for CD19+ Leukemia
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Seattle Children's Hospital
Indications

leukemia

Therapies

Autologous CD19t T-APC

Age Groups: adult child

No variant requirements are available.